Cardlytics (CDLX) Stock Price, News & Analysis

Company Overview

Cardlytics, Inc. is a financial technology and advertising company that operates a marketing platform through banks and other financial institutions. Its technology connects consumers with targeted merchant offers based on transaction data, while providing advertisers with a way to reach customers through digital banking applications and other financial channels.

The company’s platform supports merchant-funded rewards, cash-back promotions and purchase-based advertising. Participating consumers can receive offers from retailers, restaurants, travel providers and other businesses, while advertisers can use Cardlytics’ data and measurement tools to target audiences and evaluate whether campaigns lead to purchases.

Cardlytics was founded in 2008 by Scott Grimes and Lynne Laube and is headquartered in Atlanta, Georgia. The company primarily serves advertisers, financial institutions and consumers in the United States and the United Kingdom. Its business has historically centered on partnerships with banks and other financial institutions that distribute Cardlytics-powered offers through their digital banking platforms.

Key Stats

• Today's Range: $1.78 to $2.20
• 50-Day Range: $1.60 to $4.28
• 52-Week Range: $1.57 to $19.50
• Volume: 214,716 shs
• Average Volume: 89,009 shs
• Market Capitalization: $12.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Sell

Cardlytics Stock Analysis - MarketRank™

Cardlytics scored higher than 43% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.9 / 5
• Analyst Rating: Sell

Consensus Rating

Cardlytics has received a consensus rating of Sell. The company's average rating score is 1.33, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 2 sell ratings.

Upside Potential

Cardlytics has a consensus price target of $10.00, representing about 381.9% upside from its current price of $2.08.

Amount of Analyst Coverage

Cardlytics has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cardlytics are expected to grow in the coming year, from ($3.89) to $1.90 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardlytics is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardlytics is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.12% of the float of Cardlytics has been sold short.

Short Interest Ratio / Days to Cover

Cardlytics has a short interest ratio ("days to cover") of 5.41.

Change versus previous month

Short interest in Cardlytics has recently decreased by 16.12%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cardlytics does not currently pay a dividend.

Dividend Growth

Cardlytics does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.60

News Sentiment

Cardlytics has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Communication Services companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Cardlytics this week, compared to 2 articles on an average week.

Search Interest

2 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $100,568.00 in company stock.

Percentage Held by Insiders

5.90% of the stock of Cardlytics is held by insiders.

Percentage Held by Institutions

68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 11/02/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Communication Services
• Industry: Media
• Sub-Industry: Advertising
• Current Symbol: NASDAQ:CDLX
• CIK: 1666071
• Web: www.cardlytics.com
• Phone: (888) 798-5802
• Fax: N/A
• Employees: 224
• Year Founded: 2008

Price Target and Rating

• Average Price Target for Cardlytics: $10.00
• High Price Target: $10.00
• Low Price Target: $10.00
• Potential Upside/Downside: +381.9%
• Consensus Rating: Sell
• Rating Score (0-4): 1.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($18.48)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1.09
• P/E Growth: N/A
• Net Income: -$103.49 million
• Net Margins: -55.92%
• Pretax Margin: -61.10%
• Return on Equity: -956.56%
• Return on Assets: -38.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.62
• Quick Ratio: 1.62

Sales & Book Value

• Annual Sales: $233.27 million
• Price / Sales: 0.05
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.20) per share
• Price / Book: -1.73

Miscellaneous

• Outstanding Shares: 5,810,000
• Free Float: 5,465,000
• Market Cap: $12.06 million
• Optionable: Optionable
• Beta: 0.70